Shanghai's NeuroXess raises $105M Series B for brain-computer interface tech
The Chinese BCI startup will use the RMB 700 million round to fund clinical trials, regulatory filings and a 10,000-unit manufacturing facility.
What to know
- NeuroXess raised RMB 700 million (~$105 million) in a Series B round for implantable brain-computer interface technology.
- The company has completed 65 clinical cases and launched a registration trial spanning nearly 20 hospitals as of July.
- Funds will support a 14,300-square-meter manufacturing facility planned for annual capacity of 10,000 systems.
NeuroXess Chinese BCI startupSDIC Juli Co-lead investorShenzhen Capital Group Co-lead investorQinzhi Capital Co-lead investor
How it unfolded 1 development · click the chart to see its coverage articlesposts
-
1
Techmeme aggregates NeuroXess funding report
Techmeme's roundup picked up TechNode's coverage of the NeuroXess Series B, bringing wider attention to the funding news.
-
S
Brain-computer interface startup # NeuroXess raises RMB 700 million in Series B funding https:// technode.com/2026/10/28/brain- computer-interface-startup-neuroxess-raises-rmb-700-million-in-series-b-funding/ Some US $100 million; # BCI NeuroTech
-
-
background
NeuroXess closes RMB 700 million Series B round — The Shanghai-based BCI startup raised roughly $105 million co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital, to fund clinical trials, regulatory submissions, manufacturing capacity and next-generation product development.